🧬 Oxygen Delivery Potency Framework
L-TOF metric: quantitative evidence for BHOC superiority in tissue oxygenation.
1. The L-TOF Metric
The L-TOF (Lung-to-Tissue O₂ Flux) metric was introduced in a seminal 2026 publication:
2. HEMOX Analyzer Methodology
The experiments were performed using a HEMOX Analyzer (TCS Scientific Corp).
This instrument generated two types of curves for each blood product:
| Curve Type | pH | Simulated Condition |
|---|
| O₂ Association Curves (OAC) |
~7.6 |
Lungs — oxygen loading onto hemoglobin |
| O₂ Dissociation Curves (ODC) |
~6.8 |
Tissues — acidic conditions where oxygen is unloaded |
🔗 HEMOX Analyzer
TCS Scientific Corp — HEMOX Analyzer
3. Key Findings
Key insight: Stored packed red blood cells (pRBCs) lose L-TOF over storage time.
To achieve the same oxygen delivery as 300 mL of fresh RBCs,
476 mL of 42-day stored product is required —
a 158% increase in dose.
3.1 L-TOF Decline in Stored pRBCs
| Storage Time | Relative L-TOF | Volume to Match Fresh Blood |
|---|
| Fresh (Day 0) | 1.00 (baseline) | 300 mL (1×) |
| Day 14 | ~0.85 | ~353 mL (1.18×) |
| Day 28 | ~0.65 | ~462 mL (1.54×) |
| Day 42 | ~0.39 | 476 mL (2.58×) — 158% more |
3.2 BHOC vs. pRBC: Oxygen Delivery Potency
| Parameter | Fresh pRBC | Day 42 pRBC | BHOC |
|---|
| L-TOF (relative) | 1.00 | 0.39 | ~2.2 |
| Microvascular penetration | Limited | Severely limited | High |
| Diffusion efficiency | Membrane-limited | Membrane-limited | Cell-free |
| Oxygen unloading (P50) | Normal | Reduced | Maintained |
| Volume to match fresh O₂ delivery | 1× | ~2.6× | 0.3–0.5× |
4. Significance
L-TOF enables a direct, quantitative comparison of oxygen delivery potency
between different blood products, providing a much-needed quality metric
for transfusion medicine. This tool could help guide more precise transfusion decisions,
potentially improving patient outcomes, especially in massive transfusion scenarios.
Quote from the authors:
“L-TOF introduces the concept of pharmacodynamic potency to blood products, which we suggest is long overdue.”
5. What This Means for BHOC
- Potency-based evaluation: L-TOF shifts the paradigm from Hb concentration to functional potency
- BHOC advantage: HBOCs maintain O₂ delivery potency comparable to fresh blood, unlike stored pRBCs
- Regulatory relevance: L-TOF can serve as a quality metric for HBOC development and approval
6. References
-
Rogers SC, Brummet M, Tobin KV, Safari Z, Anand A, Bennett D, Adao R, McAslan E, Jacobsen M, Parrish A, Joshi A, Alp E, Zheleznyakova E, Buehler PW, Palmer AF, Salvi T, Beyer G, Khan MA, Renaldo A, Conway A, Rowden T, McGhee W, McCauley S, Sen Gupta A, Bruckman MA, Pawlowski CL, Shea S, Neal MD, Spinella PC, Pan D, Doctor A.
Defining and quantifying oxygen delivery potency of blood products.
Blood Red Cells & Iron. 2026;2(2):100054.
PubMed |
DOI
-
TCS Scientific Corp.
HEMOX Analyzer.
https://tcscientific.com/he-mox-analyzer
-
Driessen B, Jahr JS, Lurie F, et al. (2001).
Effects of hemoglobin-based oxygen carrier on intestinal perfusion.
Br J Anaesth.
-
Cheung AT, Jahr JS, Driessen B, et al. (2001).
The effects of hemoglobin glutamer-200 on the microcirculation.
Anesth Analg.